Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bridge Laboratories to build second facility in China
According to Bridge Laboratories, construction of the new laboratory will begin in the fourth quarter of 2008. This facility, expected to be completed in late fourth quarter of
According to Bridge Laboratories, construction of the new laboratory will begin in the fourth quarter of 2008. This facility, expected to be completed in late fourth quarter of
Protein Sciences company (PSC) has cited multiple breaches by Emergent including disclosure and mischaracterization of PSC’s material confidential information obtained from PSC during due diligence and Emergent’s failure
This change of partner in North America follows the decision made by Endo Pharmaceuticals Holdings following its own internal strategy changes to return all rights for Rapinyl (Abstral)
According to the study, the Medicare program has paid an average of 30% more than Medicaid (the program covering people on low incomes) for the same prescription drugs.
According to the report, there is an inordinate delay in taking action on companies which practice off-label prescribing. While the federal agencies take approximately seven months to issue
The senate focused on the companies who were believed to have abused the orphan status of the drugs granted by the 1983 Orphan Drug Act and engaged in
Pfizer Australia was fined $200,000 after it was proved that its representatives in NSW and Queensland misinformed the doctors about a cholesterol-lowering drug produced by rival AstraZeneca. The
In spinal applications, Plexur M may be used in conjunction with autograft as bone void filler. Previously, Osteotech has received the FDA clearance for Plexur M to be
As part of a five year agreement, Berry & Associates is providing Applied Biosystems a custom nucleoside phosphoramidite that meets the high purity standards required for synthesis of
The total purchase price is expected to total approximately $20 million in cash and assumed indebtedness. Paul Viviano, chairman of the board and CEO of Alliance Imaging, said: